NASDAQ: RXRX

Financial Scores

RXRX’s valuation metrics: A comprehensive analysis

Arcelia Reed

Recursion Pharmaceuticals Inc (RXRX)’s stock has witnessed a price declined of -2.89% from the previous close with its current price ...

Financial Scores

RXRX’s price-to-sales ratio: Is it a good investment opportunity?

Arcelia Reed

Recursion Pharmaceuticals Inc (RXRX)’s stock has witnessed a price hike of 4.08% from the previous close with its current price ...

Financial Scores

RXRX’s Q2 earnings predictions: What the experts say

Cameron Mitchell

Recursion Pharmaceuticals Inc (RXRX)’s stock has witnessed a price hike of 2.33% from the previous close with its current price ...

Analyst Snapshot

Examining RXRX’s book value per share for the latest quarter

Kenneth Phillips

Currently, Recursion Pharmaceuticals Inc’s (RXRX) stock is trading at $4.21, marking a fall of -0.84% from last night’s close. At ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.